Unicycive Therapeutics, Inc. Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • Unicycive Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $20K, a 66.7% increase year-over-year.
  • Unicycive Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $90K.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2023 was $82K, a 1267% increase from 2022.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2022 was $6K, a 99% decline from 2021.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2021 was $628K, a 157% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $82K +$76K +1267% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6K -$622K -99% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $628K +$384K +157% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $244K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.